Peyronies Society Forums

Peyronies Disease TREATMENT Discussion Boards => Developmental Drugs & Treatments => Topic started by: pey ron on May 07, 2018, 09:44:45 PM

Title: Rho-Kinase Inhibition
Post by: pey ron on May 07, 2018, 09:44:45 PM
I just found this new article from the awesome Marcus M Ilg that already presented those posters on high throughput screening of drugs for Peyronie:

«RhoA kinase-inhibition prevents myofibroblast transformation in a cell culture model of Peyronie's disease»
10.1016@S1569-90561831811-6.pdf - DocDroid (http://docdro.id/iRJRm0R)

It looks like Rho-Kinase might be a target for diabetes too...

«Rho-Kinase Inhibition Ameliorates Metabolic Disorders through Activation of AMPK Pathway in Mice»
Rho-Kinase Inhibition Ameliorates Metabolic Disorders through Activation of AMPK Pathway in Mice (http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0110446)

BRB, I need to stock up on Ganoderma lingzhi amen2017.pdf - DocDroid (http://docdro.id/mnAmvkn) and adlay seeds amen2017b.pdf - DocDroid (http://docdro.id/cySiHwk) ...

Title: Re: Rho-Kinase Inhibition
Post by: happyman on February 28, 2024, 06:45:06 PM
pey ron,

good to see your active. did you ever follow up on this? i, myself, have been looking into fasudil (not available in us) and Y-27632